Association of European Cancer Leagues - ECL https://validator.w3.org/feed/docs/rss2.html Some hospitals pay more than double for the same cancer drugs Our team Working groups Policy paper: Regulating novel and emerging nicotine and tobacco products Patient Support A call on countries to ensure access to affordable medicines Access to Medicines Early detection Cancer prevention Letter: The next EU budget can be a driver for clean air European Week Against Cancer Wolfgang Fecke appointed as ECL’s new Executive Director Vacancies Vacancy: Implementation Policy Officer (Freelance) Youth Ambassadors Ensuring equitable access: Cancer leagues call for an ambitious Critical Medicines Act How to manage cancer at work: Tips for employers supporting employees with cancer International Workers’ Day 2025 Tobacco industry infiltrates advisory process on EU Tobacco Tax Directive Tobacco taxes remain the most cost-effective measure to reduce tobacco consumption  EU Healthy Air Coalition launches new infographic to mark Clean Air Day ECL responds to EU consultation on the Tobacco Tax Directive revision  European Cancer Leagues call on EU Commissioner Hoekstra to prevent cancer by strengthening the EU Tobacco Taxation Directive Letter: European collaboration on equal access to cancer medicines and the role of EU competition policy Letter: Supporting the Italian draft resolution on improving the transparency of markets for medicines and vaccines Letter: Request to start an investigation into the factors leading to medicines shortages Letter: Prevention of medicine shortages through the constitution of safety stocks Letter: Publish the proposed revision of the EU pharmaceutical legislation NOW Letter: Cancer patients need a patient-centred and fit for purpose pharmaceutical system Letter to President von der Leyen: Delayed publication of the EU pharmaceutical legislation revision ECL welcomes the Council’s agreement on a mandate to start negotiations on health technology assessments (HTA) ECL welcomes the Council’s mandate to start negotiations on the HTA file Infographic: Access to medicines for all cancer patients Position paper: European cooperation on Health Technology Assessment (HTA) White Paper: Tackling challenges in access to medicines for all cancer patients How the European Medicines Agency engages with medicine producers before they apply for authorisations Public consultation: European Medicines Agency Regulatory Science to 2025  Report: What’s next on transparency? Public consultation: Europe’s Beating Cancer Plan Roadmap  Public consultation: The Pharmaceutical Strategy Roadmap  Joint recommendations: Towards fair prices of medicines in Europe  Public consultation: Pilot project ‘Market Launch of Intentions of Centrally Authorised Products’ Public consultation: Intellectual Property Action Plan  Position paper: Europe’s Pharmaceutical Strategy  New European Commission report confirms urgent need to reform EU tobacco rules Report: What is fair pricing? Support of Aspen Pharma commitments on excessive pricing   ECL’s contribution to the 2021 WHO Fair Pricing Forum  Civil society recommendations for improving the Orphan and Paediatric Regulations  Home